SOTHEMA (CAS:SOT) Other Long-Term Liabilities: MAD119 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAS:SOT SOTHEMA CAS:SOT
83 GF Score
Price MAD370.00
GF Value MAD288.29
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is SOTHEMA Other Long-Term Liabilities?

SOTHEMA CAS:SOT +1.37% 83 Other Long-Term Liabilities is MAD119 Mil as of Dec. 2025. GuruFocus rates CAS:SOT with a GF Score™ of 83/100 and a GF Value™ of MAD288.29 (Modestly Overvalued). The stock has 5 warning signs investors should review.

SOTHEMA's other long-term liabilities for the quarter that ended in Dec. 2025 was MAD119 Mil.

SOTHEMA's quarterly other long-term liabilities declined from Dec. 2024 (MAD113 Mil) to Jun. 2025 (MAD108 Mil) but then increased from Jun. 2025 (MAD108 Mil) to Dec. 2025 (MAD119 Mil).

SOTHEMA's annual other long-term liabilities increased from Dec. 2023 (MAD112 Mil) to Dec. 2024 (MAD113 Mil) and increased from Dec. 2024 (MAD113 Mil) to Dec. 2025 (MAD119 Mil).

SOTHEMA Other Long-Term Liabilities Related Terms

SOTHEMA Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for SOTHEMA's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SOTHEMA Other Long-Term Liabilities Chart

SOTHEMA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 91.30 113.34 111.54 112.67 119.39

SOTHEMA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 111.54 104.60 112.67 108.16 119.39
CAS:SOT
83GF Score
SOTHEMA CAS:SOT
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SOTHEMA Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of MAD119 Mil mean?
SOTHEMA (CAS:SOT) has a Other Long-Term Liabilities of MAD119 Mil as of Dec. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on SOTHEMA and its competitors.
Is SOTHEMA's Other Long-Term Liabilities too high?
SOTHEMA's current Other Long-Term Liabilities is MAD119 Mil. Overall, SOTHEMA has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SOTHEMA's Other Long-Term Liabilities compare to LLY and JNJ?
SOTHEMA's Other Long-Term Liabilities of MAD119 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Drug Manufacturers company?
A good Other Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on SOTHEMA and its competitors. SOTHEMA's current Other Long-Term Liabilities is MAD119 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOTHEMA stock overvalued right now?
Based on GuruFocus' analysis, SOTHEMA (CAS:SOT) is currently considered Modestly Overvalued. The stock's GF Value™ is MAD288.29, compared to a current price of MAD370.00 — trading 28.3% above its estimated fair value. The current Other Long-Term Liabilities is MAD119 Mil. SOTHEMA's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For SOTHEMA (CAS:SOT), the current Other Long-Term Liabilities is MAD119 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SOTHEMA (CAS:SOT) Overvalued in 2026?

Based on GuruFocus' analysis, SOTHEMA stock appears to be overvalued. The current stock price of MAD370.00 is trading 28.3% above its estimated GF Value™ of MAD288.29. GuruFocus considers SOTHEMA to be Modestly Overvalued.

Key valuation signals for CAS:SOT:

  • Other Long-Term Liabilities: MAD119 Mil
  • GF Value™: MAD288.29 vs. price of MAD370.00 (28.3% above fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the CAS:SOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SOTHEMA Business Description

Address Centre de Bouskoura, BP no. 1, Casablanca, MAR
SOTHEMA engages in representation, purchase and sale of pharmaceutical, chemical, health-related, biological, veterinary, plant-based, cosmetic and scented products. The company sells its products in Morocco and overseas.
83GF Score

Get the complete analysis for CAS:SOT

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MAD370.00
Price
MAD288.29
GF Value